| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/24/2001 | CN1281362A Novel combination medicine |
| 01/24/2001 | CN1281361A Use of aromatase inhibitor in treatment of uropoiesis disease and method for studying uropoiesis disease |
| 01/24/2001 | CN1281360A Use of substituted amidino compounds in treatment of chronic obstructive pulmonary disease |
| 01/24/2001 | CN1281359A Use of thiazolidinediones for treatment of hyperglycaemia |
| 01/24/2001 | CN1281358A Use of thiazolidinediones for treatment of hyperglycaemia |
| 01/24/2001 | CN1281357A Medicaments |
| 01/24/2001 | CN1281355A Biodegradable mixed polymeric micelles for gene delivery |
| 01/24/2001 | CN1281354A Topical compositions for regulating oily/shiny appearance of skin |
| 01/24/2001 | CN1281335A Treatment of schizophrenia with ampakines and neuroleptics |
| 01/24/2001 | CN1281334A Method for treating Alzheimer's disease |
| 01/24/2001 | CN1281050A Process for preparing ginkgolic polyose by culturing ginkgolic cells |
| 01/24/2001 | CN1280856A Composition of stable bioactive substances and its preparing process |
| 01/24/2001 | CN1280855A Medicinal composition containing algal protein polyose extract and extraction of algal protein polyose |
| 01/24/2001 | CN1280854A Detoxicating nutritive liquor and its preparing process |
| 01/24/2001 | CN1280829A Konjak-glucomannan capsule |
| 01/24/2001 | CN1280828A Hemostatic algin powder |
| 01/24/2001 | CN1280827A Sigma receptor action medicine containing alkaloid |
| 01/24/2001 | CN1280826A Application of malaridine in preparing antitumor medicine and tumor tolerance-reversing medicine |
| 01/24/2001 | CN1280825A Sigma-receptor acting medicine containing protopine-type alkaloid |
| 01/24/2001 | CN1280770A Povidone iodine solution of multi-element dispersion medium |
| 01/24/2001 | CN1061052C 11 Beta-aromatic group-4-estraene and acid additive salt application in medicine |
| 01/24/2001 | CN1061050C Ureido derivatives of naththalenephosphonic acids and process for their preparation |
| 01/24/2001 | CN1061049C Sulfur-containing phosphonate compounds, pharmaceutical compositions and use thereof |
| 01/24/2001 | CN1061047C Process of preparing etoposide phosphate |
| 01/24/2001 | CN1061046C Process for preparing cephalosporins derivants |
| 01/24/2001 | CN1061045C Process for preparation of new cephalosporins containing in position 7 substituted benzyloxyimino radical |
| 01/24/2001 | CN1061044C Tricyclic 5,6-dihydro-9H-pyrazolo [3,4-C]-1,2,4-triaolo [4,3-alpha] pyridines |
| 01/24/2001 | CN1061043C Benzo-iso-thiazolyl substituted amino methyl benzodipyran |
| 01/24/2001 | CN1061042C Adhesion receptor antagonists |
| 01/24/2001 | CN1061041C Piperidine derivatives |
| 01/24/2001 | CN1061036C Substituted pyrazolyl benzenesulfonamides for treating inflammation |
| 01/24/2001 | CN1061035C Phenylalkanolamine derivatives and its preparing process and use |
| 01/24/2001 | CN1060948C Auxiliary table and aspirin in application for treating mental retardation |
| 01/24/2001 | CN1060933C Application of googerotin used as antineoplastic medicine |
| 01/23/2001 | USRE37029 Antipsychotic and analgesic agents |
| 01/23/2001 | US6177594 4-(4-oxocyclohexyl) benzamides as intermediate products for medicaments |
| 01/23/2001 | US6177592 Compounds |
| 01/23/2001 | US6177579 Process for the preparation of 13-cis-retinoic acid |
| 01/23/2001 | US6177572 Solid and liquid-phase synthesis of benzoxazoles and benzothiazoles and their use |
| 01/23/2001 | US6177568 Intermediates for the synthesis of camptothecin derivatives |
| 01/23/2001 | US6177561 Preparation of acid amides and metallization of compounds |
| 01/23/2001 | US6177560 Direct esterification of the 17 hydroxyl group without prior protection of the free 11 hydroxy function. |
| 01/23/2001 | US6177550 Process for extraction of a growth factor complex |
| 01/23/2001 | US6177478 Using an amine polymer; prevent kidney stones |
| 01/23/2001 | US6177477 Sterile oil in water emulsion for parenteral administration; mixture containing tromethamine |
| 01/23/2001 | US6177476 Administering a glycerol ether compound |
| 01/23/2001 | US6177475 Methods of using integrin modulators for treatment of inflammation |
| 01/23/2001 | US6177474 Aromatic compound containing ketone and hydroxy groups |
| 01/23/2001 | US6177473 Factor x inhibitor |
| 01/23/2001 | US6177472 Prevent fatty acid release using terpene |
| 01/23/2001 | US6177471 Method for treating patients with acne by administering a CGMP-specific PDE inhibitor |
| 01/23/2001 | US6177470 Prostaglandin synthesis |
| 01/23/2001 | US6177469 Antiutor agents; autoimmune diseases |
| 01/23/2001 | US6177468 Modulation of inflammation related to columnar epithelia |
| 01/23/2001 | US6177464 Bactericides |
| 01/23/2001 | US6177460 Using a n-chlorophenyl(thio)carbamate |
| 01/23/2001 | US6177458 Alzheimer's disease |
| 01/23/2001 | US6177457 Cyclization of chemical intermediates; fungicides |
| 01/23/2001 | US6177455 Administering a nitrogen-containing heterocyclic compound |
| 01/23/2001 | US6177454 Antidiabetic agents |
| 01/23/2001 | US6177453 Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus |
| 01/23/2001 | US6177451 For humans; parkinson's, tourelle's, and alzheimer's diseases |
| 01/23/2001 | US6177450 Synergizing combination having an antagonist effect on NKI and NK2 receptors |
| 01/23/2001 | US6177449 Cardiovascular disorders; antiulcer agents |
| 01/23/2001 | US6177448 Therapy for chemokine sensitivie disease |
| 01/23/2001 | US6177447 Therapy for gaucher's disease |
| 01/23/2001 | US6177445 Substituted isoquinolines as ultra short acting neuromuscular blockers |
| 01/23/2001 | US6177444 Allosteric adenosine receptor modulators |
| 01/23/2001 | US6177443 Antidiabetic agents |
| 01/23/2001 | US6177442 Bicyclic amine derivatives |
| 01/23/2001 | US6177441 Treating red blood cell solutions with anti-viral agents |
| 01/23/2001 | US6177437 Viricides |
| 01/23/2001 | US6177436 Administering with viricide; side effect reduction |
| 01/23/2001 | US6177435 Therapeutic combinations |
| 01/23/2001 | US6177434 Prevention or reversal of sensorineural hearing loss (SNHL) through biologic mechanisms |
| 01/23/2001 | US6177433 Administering a tyrosine kinase inhibitor |
| 01/23/2001 | US6177432 Farnesyltransferase inhibiting quinazolinones |
| 01/23/2001 | US6177430 Use of α1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia |
| 01/23/2001 | US6177429 Dihydropyrazine derivatives as NPY antagonists |
| 01/23/2001 | US6177428 Treatment of sexual dysfunction; stimulation of endogenous nitrogen monoxide synthesis |
| 01/23/2001 | US6177427 Treatment of glaucoma and ocular hypertension |
| 01/23/2001 | US6177426 Morpholino-N-ethyl ester prodrugs of indole sPLA2 inhibitors |
| 01/23/2001 | US6177425 Stereospecific enantiomer having antiinflammatory and neutrophil elastase inhibiting activity; for treatment of chronic bronchitis in humans or animals |
| 01/23/2001 | US6177423 N-(hydroxy or protected hydroxy)-benzo(de)isoquinoline-1,3-dione derivatives; bacterial dna gyrase and dna topoisomerase inhibitors useful for antibacterial agents having reduced drug resistance and reduced side effects |
| 01/23/2001 | US6177420 Fertility control agents; side effect reduction |
| 01/23/2001 | US6177419 Antioxidant chelate compounds for preventing oxygen free radical-associated diseases in mammals; neuroprotectants, superoxide dismutase (sod), catalase (cat) and/or peroxidase (pod) mimetics |
| 01/23/2001 | US6177418 Epoxidized and/or hydroxylated prostane derivatives derived from a fusidium coccineum fungus metabolite isolated from metabolite mixture of fusidic acid |
| 01/23/2001 | US6177417 Cholanic acid ring based 4-(trifluoroacetyl)phenyl derivatives, process for preparation and use thereof |
| 01/23/2001 | US6177415 Bacteriohopanetetrol and related compounds useful for modulation of lipoxygenase activity and anti-inflammatory applications |
| 01/23/2001 | US6177413 Dissolving salicylic acid and acetylsalicylic acid in aqueous potassium hydroxide, drying, mixing the salt with a liquid carrier |
| 01/23/2001 | US6177411 Method for treating heavy metal poisoning |
| 01/23/2001 | US6177408 Compounds such as 3-(1-methyl-4(1-methyl-4(1-methyl-4(4-n,n-bis(2 -chloroethyl)aminocinnamoylamido)pyrrole-2-carboxamido)pyrrole-2 -carboxamido)pyrrole-2-carboxamido)propionamidine |
| 01/23/2001 | US6177403 Compositions, methods, and apparatus for delivery of a macromolecular assembly to an extravascular tissue of an animal |
| 01/23/2001 | US6177401 Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis |
| 01/23/2001 | US6177273 Antisense modulation of integrin-linked kinase expression |
| 01/23/2001 | US6177264 Nucleotide sequences isolated from coryneform which code for ketopantoate hydroxymethyltransferase and pantothenate synthetase of defined amino acid sequences; for recombinant production |
| 01/23/2001 | US6177257 Immunoassay diagnosis of susceptibility to atherosclerosis by analyzing blood for presence of enzyme using polyclonal or monoclonal antibodies; elevated levels are indicative of susceptibility |
| 01/23/2001 | US6177246 Contacting a tissue or cell with an oligonucleotide of defined nucleotide sequence which hybridizes to nucleic acid encoding abnormally expressed beta-amyloid precursor protein; prophylaxis and treatment of alzheimer's disease |
| 01/23/2001 | US6177122 Cancer chemoprotective food products |
| 01/23/2001 | US6177103 Processes to generate submicron particles of water-insoluble compounds |